Cargando…
Predicting Anticancer Drug Response With Deep Learning Constrained by Signaling Pathways
Thanks to the availability of multiomics data of individual cancer patients, precision medicine or personalized medicine is becoming a promising treatment for individual cancer patients. However, the association patterns, that is, the mechanism of response (MoR) between large-scale multiomics featur...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581064/ https://www.ncbi.nlm.nih.gov/pubmed/36303766 http://dx.doi.org/10.3389/fbinf.2021.639349 |